{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,30]],"date-time":"2025-05-30T06:09:16Z","timestamp":1748585356636},"reference-count":9,"publisher":"Japanese Society of Internal Medicine","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2024,1,15]]},"DOI":"10.2169\/internalmedicine.1942-23","type":"journal-article","created":{"date-parts":[[2023,5,23]],"date-time":"2023-05-23T22:12:39Z","timestamp":1684879959000},"page":"319-322","source":"Crossref","is-referenced-by-count":1,"title":["Anti-leucine-rich Glioma-inactivated 1 Protein-antibody Positive Encephalitis with Extensive Unilateral Cerebral Cortex and White Matter Lesions"],"prefix":"10.2169","volume":"63","author":[{"given":"Hideo","family":"Kihara","sequence":"first","affiliation":[{"name":"Department of Neurology, Toho University Ohashi Medical Center, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shingo","family":"Konno","sequence":"additional","affiliation":[{"name":"Department of Neurology, Toho University Ohashi Medical Center, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takafumi","family":"Uchi","sequence":"additional","affiliation":[{"name":"Department of Neurology, Toho University Ohashi Medical Center, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Isonishi","sequence":"additional","affiliation":[{"name":"Department of Neurology, Toho University Ohashi Medical Center, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hideki","family":"Sugimoto","sequence":"additional","affiliation":[{"name":"Department of Neurology, Toho University Ohashi Medical Center, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshiki","family":"Fujioka","sequence":"additional","affiliation":[{"name":"Department of Neurology, Toho University Ohashi Medical Center, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Ohkawa T, Fukata Y, Yamasaki M, et al. Autoantibodies to epilepsy-related LGI1 in limbic encephalitis neutralize LGI1-ADAM22 interaction and reduce synaptic AMPA receptors. J Neurosci 33: 18161-18174, 2013.","DOI":"10.1523\/JNEUROSCI.3506-13.2013"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Ghimire P, Khanal UP, Gajurel BP, et al. Anti-LGI1, anti-GABABR, and anti-CASPR2 encephalitides in Asia: a systematic review. Brain Behav 10: e01793, 2020.","DOI":"10.1002\/brb3.1793"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Li W, Wu S, Meng Q, et al. Clinical characteristics and short-term prognosis of LGI1 antibody encephalitis: a retrospective case study. BMC Neurol 18: 96, 2016.","DOI":"10.1186\/s12883-018-1099-z"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. van Sonderen A, Thijs RD, Coenders EC, et al. Anti-LGI1 encephalitis: clinical syndrome and long-term follow-up. Neurology 87: 1449-1456, 2016.","DOI":"10.1212\/WNL.0000000000003173"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Chen W, Wang M, Gao L, et al. Neurofunctional outcomes in patients with anti-leucine-rich glioma inactivated 1 encephalitis. Acta Neurol Scand 144: 632-639, 2021.","DOI":"10.1111\/ane.13503"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Olszewski C, Thomson S, Strauss L, et al. Patient experiences with ambulatory telehealth in neurology: results of a mixed-methods study. Neurol Clin Pract 11: 484-496, 2021.","DOI":"10.1212\/CPJ.0000000000001072"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Dubey D, Britton J, McKeon A, et al. Randomized placebo-controlled trial of intravenous immunoglobulin in autoimmune LGI1\/CASPR2 epilepsy. Ann Neurol 87: 313-323, 2020.","DOI":"10.1002\/ana.25655"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Graus F, Titulaer MJ, Balu R, et al. A clinical approach to the diagnosis of autoimmune encephalitis. Lancet Neurol 15: 391-404, 2016.","DOI":"10.1016\/S1474-4422(15)00401-9"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Lin N, Liu Q, Chen J, et al. Long-term seizure outcomes in patients with anti-leucine-rich glioma-inactivated 1 encephalitis. Epilepsy Behav 122: 108159, 2021.","DOI":"10.1016\/j.yebeh.2021.108159"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/63\/2\/63_1942-23\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,20]],"date-time":"2024-01-20T03:21:38Z","timestamp":1705720898000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/63\/2\/63_1942-23\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,15]]},"references-count":9,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.1942-23","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,1,15]]},"article-number":"1942-23"}}